These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24937185)

  • 1. Development of second generation EP2 antagonists with high selectivity.
    Ganesh T; Jiang J; Dingledine R
    Eur J Med Chem; 2014 Jul; 82():521-35. PubMed ID: 24937185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead optimization studies of cinnamic amide EP2 antagonists.
    Ganesh T; Jiang J; Yang MS; Dingledine R
    J Med Chem; 2014 May; 57(10):4173-84. PubMed ID: 24773616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.
    Ganesh T
    Expert Opin Ther Pat; 2015 Jul; 25(7):837-44. PubMed ID: 25772215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.
    Ganesh T; Banik A; Dingledine R; Wang W; Amaradhi R
    Mol Pharm; 2018 Dec; 15(12):5809-5817. PubMed ID: 30398879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models.
    Amaradhi R; Banik A; Mohammed S; Patro V; Rojas A; Wang W; Motati DR; Dingledine R; Ganesh T
    J Med Chem; 2020 Feb; 63(3):1032-1050. PubMed ID: 31904232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid receptor EP2 as a therapeutic target.
    Ganesh T
    J Med Chem; 2014 Jun; 57(11):4454-65. PubMed ID: 24279689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.
    Sluter MN; Hou R; Li L; Yasmen N; Yu Y; Liu J; Jiang J
    J Med Chem; 2021 Aug; 64(16):11816-11836. PubMed ID: 34352171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties.
    Amaradhi R; Mohammed S; Banik A; Franklin R; Dingledine R; Ganesh T
    ACS Pharmacol Transl Sci; 2022 Feb; 5(2):118-133. PubMed ID: 35187419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal models.
    Rawat V; Banik A; Amaradhi R; Rojas A; Taval S; Nagy T; Dingledine R; Ganesh T
    Biomed Pharmacother; 2022 Mar; 147():112646. PubMed ID: 35091236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
    Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
    J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP
    Bradbury P; Rumzhum NN; Ammit AJ
    J Cell Physiol; 2019 Jul; 234(7):11070-11077. PubMed ID: 30536718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling.
    Zaslona Z; Serezani CH; Okunishi K; Aronoff DM; Peters-Golden M
    Blood; 2012 Mar; 119(10):2358-67. PubMed ID: 22234697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
    McCullough L; Wu L; Haughey N; Liang X; Hand T; Wang Q; Breyer RM; Andreasson K
    J Neurosci; 2004 Jan; 24(1):257-68. PubMed ID: 14715958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
    Takahashi T; Uehara H; Ogawa H; Umemoto H; Bando Y; Izumi K
    Oncotarget; 2015 Mar; 6(7):4829-44. PubMed ID: 25638159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
    FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.